{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:51:00Z","timestamp":1790884260916,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:00:00Z","timestamp":1543363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["260901"],"award-info":[{"award-number":["260901"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-EQPX-04-01"],"award-info":[{"award-number":["ANR-10-EQPX-04-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fond europeen de developement regional (FEDER)","award":["12001407 (D-AL)"],"award-info":[{"award-number":["12001407 (D-AL)"]}]},{"name":"R\u00e9gion Nord Pas de Calais","award":["12000080"],"award-info":[{"award-number":["12000080"]}]},{"DOI":"10.13039\/501100009104","name":"Department of Health Research","doi-asserted-by":"publisher","award":["Overseas training fellowship"],"award-info":[{"award-number":["Overseas training fellowship"]}],"id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agence Nationale de la Recherche","award":["ANR-10-EQPX-04-01"],"award-info":[{"award-number":["ANR-10-EQPX-04-01"]}]},{"name":"Fond europeen de developement regional (FEDER)","award":["12001407 (D-AL)"],"award-info":[{"award-number":["12001407 (D-AL)"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198226","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T13:29:37Z","timestamp":1543411777000},"page":"e0198226","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture"],"prefix":"10.1371","volume":"13","author":[{"given":"Pritom","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Emmanuelle","family":"Sahuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Rouill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vandeputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscille","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoranjan","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanoy","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Dubuisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9667-133X","authenticated-orcid":true,"given":"Karin","family":"S\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"R Bartenschlager","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.cgh.2010.06.032","article-title":"Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection","volume":"8","author":"IM Jacobson","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12876-016-0551-z","article-title":"Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor","volume":"16","author":"M Stepanova","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"ref4","first-page":"1","article-title":"The origin of hepatitis C virus","volume":"369","author":"P Simmonds","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13027","article-title":"Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives","volume":"36","author":"Tarik Asselah","year":"2016","journal-title":"Liver Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1038\/ctg.2016.50","article-title":"Hepatitis C Treatment and Barriers to Eradication","volume":"7","author":"MA Konerman","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"ref7","first-page":"310","article-title":"Hepatitis C Virus: A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy","volume":"4","author":"SM Lynch","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/j.1460-2075.1996.tb00329.x","article-title":"Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"15","author":"SE Behrens","year":"1996","journal-title":"EMBO J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12916-017-0815-7","article-title":"Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals","volume":"15","author":"TF Baumert","year":"2017","journal-title":"BMC Med"},{"key":"ref10","first-page":"1101","article-title":"Fields Virology","author":"BD Lindenbach","year":"2007"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13673","article-title":"Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?","volume":"38","author":"Tarik Asselah","year":"2018","journal-title":"Liver Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/v2030692","article-title":"Recent Advances in Hepatitis C Virus Cell Entry","volume":"2","author":"B Bartosch","year":"2010","journal-title":"Viruses"},{"key":"ref13","first-page":"14","article-title":"Viral infectious disease and natural products with antiviral activity","volume":"1","author":"K Kitazato","year":"2007","journal-title":"Drug Discov Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1128\/JVI.01473-15","article-title":"Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action","volume":"89","author":"N Calland","year":"2015","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.24803","article-title":"(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry","volume":"55","author":"N Calland","year":"2012","journal-title":"Hepatol Baltim Md"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.24610","article-title":"The Green Tea Polyphenol, Epigallocatechin-3-Gallate, Inhibits Hepatitis C Virus Entry","volume":"54","author":"S Ciesek","year":"2011","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ja.2016.128","article-title":"Antiviral effect of theaflavins against caliciviruses","volume":"70","author":"M Ohba","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2015.03.009","article-title":"Antiviral activity of theaflavin digallate against herpes simplex virus type 1","volume":"118","author":"A de Oliveira","year":"2015","journal-title":"Antiviral Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.fitote.2011.11.016","article-title":"A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection","volume":"83","author":"J Yang","year":"2012","journal-title":"Fitoterapia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.antiviral.2012.04.001","article-title":"In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives","volume":"94","author":"M Zu","year":"2012","journal-title":"Antiviral Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijms11010014","article-title":"Chemistry of secondary polyphenols produced during processing of tea and selected foods","volume":"11","author":"T Tanaka","year":"2009","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/JVI.68.10.6147-6160.1994","article-title":"Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses","volume":"68","author":"J Dubuisson","year":"1994","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1099\/vir.0.82872-0","article-title":"Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins","volume":"88","author":"D Delgrange","year":"2007","journal-title":"J Gen Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JVI.80.6.2832-2841.2006","article-title":"Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus","volume":"80","author":"Y Rouill\u00e9","year":"2006","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jcv.2004.03.009","article-title":"TaqMan amplification system with an internal positive control for HCV RNA quantitation","volume":"31","author":"S Castelain","year":"2004","journal-title":"J Clin Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1\u2013E2 Envelope Protein Complexes","volume":"197","author":"B Bartosch","year":"2003","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/j.gastro.2003.09.023","article-title":"Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon","volume":"125","author":"T Kato","year":"2003","journal-title":"Gastroenterology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1128\/JVI.78.14.7400-7409.2004","article-title":"Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes","volume":"78","author":"D Moradpour","year":"2004","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00705-012-1304-0","article-title":"(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus","volume":"157","author":"C Chen","year":"2012","journal-title":"Arch Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1099\/jgv.0.000537","article-title":"Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay","volume":"97","author":"RA Urbanowicz","year":"2016","journal-title":"J Gen Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"JM Timpe","year":"2008","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/AAC.00399-10","article-title":"PSI-7851, a Pronucleotide of beta-D-2 \u2018-Deoxy-2 \u2018-Fluoro-2 \u2018-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication","volume":"54","author":"AM Lam","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"M Gao","year":"2010","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1004128","DOI":"10.1371\/journal.ppat.1004128","article-title":"Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents","volume":"10","author":"F Xiao","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies","volume":"54","author":"MB Zeisel","year":"2011","journal-title":"J Hepatol"},{"key":"ref36","first-page":"1","article-title":"Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals","author":"CC Colpitts","year":"2016","journal-title":"Hepatol Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: The role of direct-acting antivirals","volume":"142","author":"G Li","year":"2017","journal-title":"Antiviral Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/v4102197","article-title":"Hepatitis C virus and natural compounds: a new antiviral approach?","volume":"4","author":"N Calland","year":"2012","journal-title":"Viruses"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.3748\/wjg.v20.i11.2941","article-title":"Medicinal plants against hepatitis C virus","volume":"20","author":"UA Ashfaq","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"S\u00e9ron K, Sahuc M-E, Rouill\u00e9 Y. Natural products and hepatitis C virus. Natural Antimicrobial Agents. Springer Nature. Jean-Michel M\u00e9rillon and C\u00e9line Riviere; 2018. p. in press.","DOI":"10.1007\/978-3-319-67045-4_12"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbagen.2005.02.012","article-title":"Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41","volume":"1723","author":"S Liu","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/jn\/136.7.1839","article-title":"Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption","volume":"136","author":"SM Henning","year":"2006","journal-title":"J Nutr"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e0163498","DOI":"10.1371\/journal.pone.0163498","article-title":"Simultaneous Determination of Black Tea-Derived Catechins and Theaflavins in Tissues of Tea Consuming Animals Using Ultra-Performance Liquid-Chromatography Tandem Mass Spectrometry","volume":"11","author":"S Ganguly","year":"2016","journal-title":"PLoS ONE"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:50:03Z","timestamp":1605487803000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198226"}},"subtitle":[],"editor":[{"given":"Ratna B.","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,28]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198226","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/325126","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,28]]}}}